S100A12 and COVID-19: We performed a study using peripheral blood mRNA-seq data from 41 COVID-19 patients to obtain the immune-characterized genes of COVID-19 severe disease, namely, the hub genes (FPR1, FCGR2A, TLR4, S100A12, CXCL1, and LTF).